Related Experiment Video
Updated: Mar 16, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Enhancing tuberculosis patient safety: The impact of interprofessional collaboration based telecare on drug-related
Devi Ristian Octavia1, Andi Hermansyah2, Yunita Nita2
1Doctoral Study Program of Pharmaceutical Science, Faculty of Pharmacy Universitas Airlangga, Kampus C UNAIR, Jl. Mulyorejo, Mulyorejo, Surabaya, East Java, 60115, Surabaya, Indonesia; Faculty of Health Sciences Universitas Muhammadiyah Lamongan, Jl. Raya Plalangan KM 02 Plosowahyu Lamongan, East Java, 62218, Indonesia.
Background:
Complex and long-term TB treatment increases the risk of drug-related problems (DRPs). Optimal TB treatment requires a multidisciplinary team, but most hospitals do not see this condition. This study aimed to analyze the impact of telecare-based IPC practices on reducing the incidence of DPRs in patients with TB.
Methods:
A Randomized Control Trial was conducted in a single-masked group with a study population of 300. Randomization was performed using a computer-generated sequence with 1:1 allocation ratio. Blinding was maintained by ensuring that the intervention and control treatments were identical in appearance with 55 participants in each group. The intervention group received telecare-based interprofessional collaboration services, whereas the control group received standard hospital services. The data were collected using an observational sheet. According to Cipolle et al. (2012), the primary outcome measured was the incidence of DRP, including unnecessary drug therapy, need for additional drug therapy, ineffective drug therapy, too high dose, too low dose, adverse drug reactions (ADR), and non-compliance. Next, the difference in the incidence of DRPs in the control and experimental groups after the IPC-based telecare practice was examined. Data were analyzed by an independent statistician blinded to group assignments using intention-to-treat principles.
Results:
The research results showed that telecare-based interprofessional collaboration practices can reduce the incidence of DRPs with a significant p-value <0.05, especially in the criteria of adverse drug reactions, drug interactions, and nonadherence in TB patients, thereby increasing patient safety efforts.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

